这是一篇来自已证抗体库的有关人类 ACTG1的综述,是根据222篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合ACTG1 抗体。
ACTG1 同义词: ACT; ACTG; DFNA20; DFNA26; HEL-176

圣克鲁斯生物技术
小鼠 单克隆(B4)
  • 免疫组化-石蜡切片; 小鼠; 图 2d
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, SC-53142)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2d). Front Immunol (2021) ncbi
小鼠 单克隆(CGA7)
  • 免疫组化-冰冻切片; 小鼠; 图 2f
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 2e
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53015)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 2f) 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 2e). Cell Prolif (2020) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 4g
圣克鲁斯生物技术 ACTG1抗体(Santa, sc-8432)被用于被用于免疫印迹在人类样本上 (图 4g). Cell Cycle (2020) ncbi
小鼠 单克隆(CGA7)
  • 免疫组化; 人类; 1:200; 图 1c
圣克鲁斯生物技术 ACTG1抗体(Santa, CGA7)被用于被用于免疫组化在人类样本上浓度为1:200 (图 1c). Science (2019) ncbi
小鼠 单克隆(B4)
  • 免疫组化; 小鼠; 1:100; 图 s1b
  • 免疫印迹; 小鼠; 1:1000; 图 6c
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-53142)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 s1b) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6c). J Clin Invest (2019) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 2e
圣克鲁斯生物技术 ACTG1抗体(Santa, sc-8432)被用于被用于免疫印迹在小鼠样本上 (图 2e). Sci Rep (2018) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 1:1000; 图 1d
  • 免疫印迹; 人类; 1:1000; 图 1d
圣克鲁斯生物技术 ACTG1抗体(Santa, C-2)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 1d). Nat Commun (2018) ncbi
小鼠 单克隆(B4)
  • 免疫印迹; 人类; 1:2500; 图 3a
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, Inc, sc-53142)被用于被用于免疫印迹在人类样本上浓度为1:2500 (图 3a). Mol Med Rep (2018) ncbi
小鼠 单克隆(B4)
  • 免疫印迹; 人类; 1:1000; 图 3a
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53142)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Mol Med Rep (2017) ncbi
小鼠 单克隆(2-4)
  • 免疫细胞化学; 小鼠; 1:1000; 图 s2e
  • 免疫印迹; 小鼠; 1:8000; 图 3c
圣克鲁斯生物技术 ACTG1抗体(SantaCruz, sc-65634)被用于被用于免疫细胞化学在小鼠样本上浓度为1:1000 (图 s2e) 和 被用于免疫印迹在小鼠样本上浓度为1:8000 (图 3c). J Cell Biol (2017) ncbi
小鼠 单克隆(1-17)
  • 免疫细胞化学; 小鼠; 1:100; 图 5a
  • 免疫印迹; 小鼠; 1:2000; 图 5b
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-65638)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 5a) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5b). Am J Pathol (2017) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc8432)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi
小鼠 单克隆(CGA7)
  • 免疫组化; 人类; 1:500
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53015)被用于被用于免疫组化在人类样本上浓度为1:500. Oncol Lett (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:1000; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Oncol Lett (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:5000; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1). Oncol Lett (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:1000; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Oncol Lett (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:500; 图 6
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6). Oncol Lett (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:200; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, SC-8432)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 1). Mol Med Rep (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:5000; 图 6
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, Sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 6). Front Oncol (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 5
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上 (图 5). PLoS Pathog (2016) ncbi
小鼠 单克隆(CGA7)
  • 免疫印迹; 人类; 1:1500; 图 2B
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53015)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 2B). Mol Med Rep (2016) ncbi
小鼠 单克隆(1-17)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 ACTG1抗体(santa Cruz, sc-65638)被用于被用于免疫印迹在人类样本上 (图 5). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(B4)
  • 免疫组化-石蜡切片; 小鼠; 图 8
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc53142)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 8). Sci Rep (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 大鼠; 1:500; 图 3
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 3). Biofactors (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:1000; 图 5
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5). Exp Ther Med (2016) ncbi
小鼠 单克隆(B4)
  • 免疫组化-石蜡切片; 大鼠; 1:100; 图 2
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-53142)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:100 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 2b
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在小鼠样本上 (图 2b). elife (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 4
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上 (图 4). Int J Mol Med (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 1:2000; 图 3
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3). Front Cell Neurosci (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1000 ng/ml; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1000 ng/ml (图 1). Nat Commun (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 1
圣克鲁斯生物技术 ACTG1抗体(santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上 (图 1). Cell Death Dis (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 2A
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 2A). Sci Rep (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 1:5000; 图 2
  • 免疫印迹; 大鼠; 1:5000; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 2) 和 被用于免疫印迹在大鼠样本上浓度为1:5000 (图 1). Biochemistry (2015) ncbi
小鼠 单克隆(H-6)
  • 免疫印迹; 大鼠; 1:500; 图 4
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-376421)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 4). Mol Med Rep (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫细胞化学; 犬; 图 1b
  • 免疫印迹; 犬; 1:1000; 图 s1d
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫细胞化学在犬样本上 (图 1b) 和 被用于免疫印迹在犬样本上浓度为1:1000 (图 s1d). Mol Biol Cell (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 2). J Transl Med (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 3a). PLoS ONE (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 6a). Mol Cancer Ther (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 犬; 1:50,000; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在犬样本上浓度为1:50,000 (图 1). BMC Cancer (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫细胞化学; 小鼠; 图 3d
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, SC-8432)被用于被用于免疫细胞化学在小鼠样本上 (图 3d). Cell Cycle (2015) ncbi
小鼠 单克隆(1-24)
  • 免疫组化; 大鼠; 图 1
  • 其他; 小鼠; 图 3
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-65635)被用于被用于免疫组化在大鼠样本上 (图 1) 和 被用于其他在小鼠样本上 (图 3). Cytoskeleton (Hoboken) (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
小鼠 单克隆(C-2)
  • 染色质免疫沉淀 ; 人类; 图 5
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc8432)被用于被用于染色质免疫沉淀 在人类样本上 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(B4)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53142)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 f6
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, C-2)被用于被用于免疫印迹在小鼠样本上 (图 f6). Sci Signal (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 大鼠; 1:4000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在大鼠样本上浓度为1:4000. Int J Mol Med (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:5000; 图 1g
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1g). Int J Obes (Lond) (2015) ncbi
小鼠 单克隆(B4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53142)被用于被用于免疫印迹在人类样本上. Mol Cell Endocrinol (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 5). Cell Death Dis (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在小鼠样本上. Diabetes (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 1
  • 免疫印迹; 小鼠; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 1) 和 被用于免疫印迹在小鼠样本上 (图 1). PLoS Pathog (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Med Rep (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 1:3000; 图 6
  • 免疫印迹; 人类; 1:3000; 图 2
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 6) 和 被用于免疫印迹在人类样本上浓度为1:3000 (图 2). Mol Med Rep (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:2000; 图 1
  • 免疫印迹; 小鼠; 1:2000; 图 2
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432HRP)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2). Autophagy (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 3). Oncotarget (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠; 图 1
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 ACTG1抗体(santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上 (图 1) 和 被用于免疫印迹在人类样本上 (图 1). Autophagy (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:5000; 图 5
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, SC-8432)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 5). Mar Drugs (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在小鼠样本上. FASEB J (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 大鼠; 图 7
圣克鲁斯生物技术 ACTG1抗体(santa Cruz, sc-8432)被用于被用于免疫印迹在大鼠样本上 (图 7). Int J Mol Med (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:2000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:2000. Nat Commun (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 ACTG1抗体(SantaCruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 4). Sci Rep (2015) ncbi
小鼠 单克隆(CGA7)
  • 免疫组化; 小鼠; 1:100; 图 4
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-53015)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 4). Mol Med Rep (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 1c
圣克鲁斯生物技术 ACTG1抗体(santa cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 1c). Mol Med Rep (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上. Sci Rep (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:1000. PLoS ONE (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在小鼠样本上. Am J Respir Cell Mol Biol (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotech, sc-8432)被用于被用于免疫印迹在人类样本上. Proteomics (2015) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc8432)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. PLoS ONE (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在小鼠样本上. Mol Cell Endocrinol (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(CGA7)
  • 免疫组化-石蜡切片; 小鼠
  • 免疫组化-石蜡切片; 豚鼠
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-53015)被用于被用于免疫组化-石蜡切片在小鼠样本上 和 被用于免疫组化-石蜡切片在豚鼠样本上. Am J Respir Cell Mol Biol (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:5000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:5000. Mol Cell Biol (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 大鼠; 1:4000
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz Biotechnology, sc-8432)被用于被用于免疫印迹在大鼠样本上浓度为1:4000. Exp Neurol (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在小鼠样本上. J Immunol (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上. J Cell Sci (2013) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上浓度为1:500. Eur J Hum Genet (2014) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-8432)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆(B4)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc-53142)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Cell Cycle (2013) ncbi
小鼠 单克隆(C-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 ACTG1抗体(Santa Cruz, sc8432)被用于被用于免疫印迹在人类样本上. Nucleic Acids Res (2013) ncbi
西格玛奥德里奇
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:4000; 图 s3-1c
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:4000 (图 s3-1c). elife (2020) ncbi
domestic rabbit 多克隆
  • 流式细胞仪; 人类; 1:1000; 图 s5g
西格玛奥德里奇 ACTG1抗体(Sigma, A2103)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 s5g). Science (2020) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 1a, 4a, 4b
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在人类样本上 (图 1a, 4a, 4b). JCI Insight (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1e
西格玛奥德里奇 ACTG1抗体(Sigma, A2103)被用于被用于免疫印迹在人类样本上 (图 1e). Transl Oncol (2020) ncbi
小鼠 单克隆(2-2.1.14.17)
  • 免疫印迹; 人类; 图 3j
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A8481)被用于被用于免疫印迹在人类样本上 (图 3j). Autophagy (2019) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:100; 图 13a
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 13a). elife (2019) ncbi
小鼠 单克隆(2-2.1.14.17)
  • 免疫印迹; 人类; 图 2d
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A8481)被用于被用于免疫印迹在人类样本上 (图 2d). Cell Death Dis (2019) ncbi
小鼠 单克隆(2-2.1.14.17)
  • 免疫组化基因敲除验证; 人类; 1:2000; 图 4b
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A8481)被用于被用于免疫组化基因敲除验证在人类样本上浓度为1:2000 (图 4b). Plasmid (2018) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 s3a
西格玛奥德里奇 ACTG1抗体(Sigma, AC-40)被用于被用于免疫印迹在人类样本上 (图 s3a). PLoS Pathog (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:8000; 图 6t
西格玛奥德里奇 ACTG1抗体(Sigma, A2103)被用于被用于免疫印迹在小鼠样本上浓度为1:8000 (图 6t). J Exp Med (2018) ncbi
小鼠 单克隆(AC-40)
  • 免疫组化-石蜡切片; pigs ; 1:200; 图 st1
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫组化-石蜡切片在pigs 样本上浓度为1:200 (图 st1). J Toxicol Pathol (2017) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 1A
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上 (图 1A). Exp Cell Res (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫细胞化学; 小鼠; 1:100; 图 6
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 6). Sci Rep (2016) ncbi
小鼠 单克隆(2-2.1.14.17)
  • 免疫印迹; 人类; 1:1000; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma, A8481)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Oncol Lett (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 1
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 1). Biosci Rep (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 6
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 6). elife (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6
西格玛奥德里奇 ACTG1抗体(Sigma, A2103)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). PLoS Pathog (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫组化; 人类; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫组化在人类样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:2000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, AC-40)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3). Int J Mol Sci (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:5000; 图 s1
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 s1). J Cell Sci (2017) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:10,000; 图 5
  • 免疫印迹; 小鼠; 1:10,000; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC-40)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 5) 和 被用于免疫印迹在小鼠样本上浓度为1:10,000 (图 4). Nat Commun (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 1
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在小鼠样本上 (图 1). Brain Behav (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:1000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma Aldrich, AC-40)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2
西格玛奥德里奇 ACTG1抗体(Sigma, A2103)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Infect Immun (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 3). Endocrinology (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 6
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 6
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 6). Mol Cancer Ther (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:1000; 图 1
西格玛奥德里奇 ACTG1抗体(Sigma, A-4700)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(AC-40)
  • 其他; 人类; 图 st1
西格玛奥德里奇 ACTG1抗体(SIGMA, AC-40)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma Aldrich, A4700)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, AC40)被用于被用于免疫印迹在人类样本上 (图 3). PLoS Pathog (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 1a
西格玛奥德里奇 ACTG1抗体(Sigma Aldrich, ac-40)被用于被用于免疫印迹在人类样本上 (图 1a). Mol Oncol (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫细胞化学; 大鼠; 图 2
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫细胞化学在大鼠样本上 (图 2). elife (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:5000
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:5000. Dis Model Mech (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 表 1
西格玛奥德里奇 ACTG1抗体(Sigma, A2103)被用于被用于免疫印迹在人类样本上 (表 1). Redox Biol (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 斑马鱼; 图 2
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在斑马鱼样本上 (图 2). J Muscle Res Cell Motil (2016) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A2103)被用于. Sci Rep (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 7
西格玛奥德里奇 ACTG1抗体(Sigma, AC-40)被用于被用于免疫印迹在小鼠样本上 (图 7). Am J Physiol Renal Physiol (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 3). BMC Cancer (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:1000; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). J Cell Sci (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在小鼠样本上 (图 4). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:2000; 图 1b
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 1b). Nat Commun (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 s7
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC-40)被用于被用于免疫印迹在小鼠样本上 (图 s7). Nat Immunol (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在小鼠样本上. Biochem J (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:2500; 图 2c
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:2500 (图 2c). Nat Commun (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:10,000; 图 s2b
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 s2b). Mol Cell (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 2
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在人类样本上 (图 2). Oncogene (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:10,000; 图 1
西格玛奥德里奇 ACTG1抗体(Sigma, 4700)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 1). Biomed Res Int (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 非洲爪蛙; 1:800; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, Ac-40)被用于被用于免疫印迹在非洲爪蛙样本上浓度为1:800 (图 3). Protoplasma (2016) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 1b
西格玛奥德里奇 ACTG1抗体(Sigma, AC-40)被用于被用于免疫印迹在人类样本上 (图 1b). PLoS Pathog (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 仓鼠; 1:2000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在仓鼠样本上浓度为1:2000 (图 3). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:1000; 图 s5
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC-40)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s5). PLoS ONE (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; pigs ; 1:5000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在pigs 样本上浓度为1:5000 (图 3). Sci Rep (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:5000; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma, AC40)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 4). Sci Rep (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 大鼠; 1:2000; 图 2
西格玛奥德里奇 ACTG1抗体(Sigma, A 4700)被用于被用于免疫印迹在大鼠样本上浓度为1:2000 (图 2). J Neurosci (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:2000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3). Cell Death Dis (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich-Aldrich, AC-40)被用于被用于免疫印迹在小鼠样本上. J Am Soc Nephrol (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 s2
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上 (图 s2). Nature (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; African green monkey; 1:5000; 图 s8
  • 免疫印迹; 大鼠; 1:5000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在African green monkey样本上浓度为1:5000 (图 s8) 和 被用于免疫印迹在大鼠样本上浓度为1:5000 (图 3). Nat Commun (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:500; 图 8
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC-40)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 8). J Cell Biol (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 2
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在小鼠样本上 (图 2). Mol Biol Cell (2015) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A2103)被用于. PLoS ONE (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:5000
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:5000. PLoS ONE (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 大鼠
西格玛奥德里奇 ACTG1抗体(Sigma Chemical, A4700)被用于被用于免疫印迹在大鼠样本上. FEBS Lett (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 s3
西格玛奥德里奇 ACTG1抗体(Sigma, AC-40)被用于被用于免疫印迹在人类样本上 (图 s3). Aging Cell (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 大鼠; 1:1000
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Int J Dev Neurosci (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类
西格玛奥德里奇 ACTG1抗体(Sigma, AC-40)被用于被用于免疫印迹在人类样本上. Oncotarget (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:10000
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:10000. J Neurosci (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:20000
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC40)被用于被用于免疫印迹在小鼠样本上浓度为1:20000. Neurobiol Dis (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 大鼠; 1:2000
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在大鼠样本上浓度为1:2000. Behav Brain Res (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; domestic goat; 1:1000; 图 3
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在domestic goat样本上浓度为1:1000 (图 3). PLoS ONE (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 图 6
西格玛奥德里奇 ACTG1抗体(Sigma, AC40)被用于被用于免疫印迹在人类样本上 (图 6). Oncogene (2015) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC40)被用于被用于免疫印迹在人类样本上. J Virol (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:10,000
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:10,000. Eur Neuropsychopharmacol (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上. J Neurosci (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 图 4
西格玛奥德里奇 ACTG1抗体(Sigma Aldrich, #AC40)被用于被用于免疫印迹在小鼠样本上 (图 4). Cancer Med (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:5000
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:5000. Biochim Biophys Acta (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫沉淀; 人类
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, AC40)被用于被用于免疫沉淀在人类样本上, 被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Mol Cells (2013) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 小鼠; 1:500
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在小鼠样本上浓度为1:500. J Neurosci (2013) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:3000
西格玛奥德里奇 ACTG1抗体(Sigma-Aldrich, A4700)被用于被用于免疫印迹在人类样本上浓度为1:3000. Head Neck (2014) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 大鼠
西格玛奥德里奇 ACTG1抗体(Sigma, AC40)被用于被用于免疫印迹在大鼠样本上. J Neurosci (2013) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 斑马鱼; 1:1000
西格玛奥德里奇 ACTG1抗体(Sigma, AC40)被用于被用于免疫印迹在斑马鱼样本上浓度为1:1000. Dev Biol (2012) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 大鼠; 1:4000
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在大鼠样本上浓度为1:4000. J Histochem Cytochem (2012) ncbi
小鼠 单克隆(AC-40)
  • 免疫印迹; 人类; 1:10,000; 图 s2
西格玛奥德里奇 ACTG1抗体(Sigma, A4700)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 s2). PLoS ONE (2010) ncbi
赛默飞世尔
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类
赛默飞世尔 ACTG1抗体(Thermo Fisher, MA5-11869)被用于被用于免疫印迹在人类样本上. PLoS ONE (2020) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 小鼠; 1:1000; 图 1b
赛默飞世尔 ACTG1抗体(thermo fisher, MA1-744)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1b). Invest Ophthalmol Vis Sci (2020) ncbi
小鼠 单克隆(HHF35)
  • 免疫组化-冰冻切片; 小鼠; 1:500; 图 2b
赛默飞世尔 ACTG1抗体(ThermoFisher, MA5-14084)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:500 (图 2b). Stem Cell Res Ther (2020) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:2000; 图 1b
赛默飞世尔 ACTG1抗体(ThermoFisher, MA5-11869)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1b). Nat Commun (2019) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:4000; 图 1b
赛默飞世尔 ACTG1抗体(Thermo fisher, MA5-11869)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 1b). Nature (2019) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:50; 图 2d
赛默飞世尔 ACTG1抗体(Thermo, MA5-11869)被用于被用于免疫印迹在人类样本上浓度为1:50 (图 2d). Nat Commun (2018) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:1000; 图 2e
赛默飞世尔 ACTG1抗体(Thermo Fisher, MS-1295-P)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2e). Nature (2017) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 斑马鱼; 1:5000; 图 s2e
赛默飞世尔 ACTG1抗体(Neomarkers, ACTN05)被用于被用于免疫印迹在斑马鱼样本上浓度为1:5000 (图 s2e). Dis Model Mech (2017) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:100; 图 1b
赛默飞世尔 ACTG1抗体(Invitrogen, MA5-11869)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 1b). Clin Sci (Lond) (2017) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 图 5g
赛默飞世尔 ACTG1抗体(Neomarkers, ACTN05)被用于被用于免疫印迹在人类样本上 (图 5g). J Cell Physiol (2017) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:300; 图 2
赛默飞世尔 ACTG1抗体(Thermo Fisher Scientific, Ab-5)被用于被用于免疫印迹在人类样本上浓度为1:300 (图 2). Oncol Lett (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; brewer's yeast; 图 2
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA1-744)被用于被用于免疫印迹在brewer's yeast样本上 (图 2). Nucleic Acids Res (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 人类; 1:500; 图 1a
赛默飞世尔 ACTG1抗体(Pierce, MA1-744)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 1a). DNA Repair (Amst) (2016) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 图 1
赛默飞世尔 ACTG1抗体(Neo Markers, ACTN05)被用于被用于免疫印迹在人类样本上 (图 1). Nucleic Acids Res (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫沉淀; 大鼠; 图 2
赛默飞世尔 ACTG1抗体(Thermo scientific, MA1-744)被用于被用于免疫沉淀在大鼠样本上 (图 2). PLoS ONE (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 拟南芥; 图 1
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA1-744)被用于被用于免疫印迹在拟南芥样本上 (图 1). Plant Physiol (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; pigs ; 图 2c
赛默飞世尔 ACTG1抗体(Thermo Scientific, mAbGEa)被用于被用于免疫印迹在pigs 样本上 (图 2c). PLoS ONE (2016) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 图 3b
赛默飞世尔 ACTG1抗体(Thermo Scientific, ACTN05)被用于被用于免疫印迹在小鼠样本上 (图 3b). Antimicrob Agents Chemother (2016) ncbi
小鼠 单克隆(HHF35)
  • 免疫组化-石蜡切片; domestic rabbit; 1:4; 图 1
赛默飞世尔 ACTG1抗体(ThermoFisher Scientific, MA5-14084)被用于被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为1:4 (图 1). Acta Histochem (2016) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 1:3000; 图 1
  • 免疫印迹; 人类; 1:3000; 图 3
赛默飞世尔 ACTG1抗体(Thermo Scientific, Ab-5)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 1) 和 被用于免疫印迹在人类样本上浓度为1:3000 (图 3). elife (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; brewer's yeast; 1:1000; 图 3
赛默飞世尔 ACTG1抗体(Thermo Fisher scientific, mAbGEa)被用于被用于免疫印迹在brewer's yeast样本上浓度为1:1000 (图 3). Nat Commun (2016) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 图 1
赛默飞世尔 ACTG1抗体(Thermo Scientific, MS-1295-P1)被用于被用于免疫印迹在人类样本上 (图 1). J Virol (2016) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 犬; 图 8
赛默飞世尔 ACTG1抗体(Neomarkers, pan Ab-5)被用于被用于免疫印迹在犬样本上 (图 8). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 小鼠; 图 2
赛默飞世尔 ACTG1抗体(Thermo Scientific, mAbGEa)被用于被用于免疫印迹在小鼠样本上 (图 2). Invest Ophthalmol Vis Sci (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:10,000; 图 3
赛默飞世尔 ACTG1抗体(Pierce Biotechnology, MA5-11869)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 3). Mol Med Rep (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA5-11869)被用于被用于免疫印迹在人类样本上. Breast Cancer Res (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; fruit fly ; 1:4000; 图 9
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA5-11869))被用于被用于免疫印迹在fruit fly 样本上浓度为1:4000 (图 9). PLoS Biol (2015) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; brewer's yeast; 1:1000; 图 2, 4
赛默飞世尔 ACTG1抗体(Fisher, MA1-744)被用于被用于免疫印迹在brewer's yeast样本上浓度为1:1000 (图 2, 4). Nat Commun (2015) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 拟南芥; 1:1000; 图 1
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA1-744)被用于被用于免疫印迹在拟南芥样本上浓度为1:1000 (图 1). Plant Physiol (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 1:500; 图 5a
赛默飞世尔 ACTG1抗体(Thermo Fisher, MA5-11869)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5a). Eur J Pharmacol (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类
赛默飞世尔 ACTG1抗体(Lab Vision, Ab-5)被用于被用于免疫印迹在人类样本上. J Transl Med (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 1:500
赛默飞世尔 ACTG1抗体(Thermo Fisher, MA5-11869)被用于被用于免疫印迹在小鼠样本上浓度为1:500. J Ethnopharmacol (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠
赛默飞世尔 ACTG1抗体(Thermo Scientific, ACTN05)被用于被用于免疫印迹在小鼠样本上. Eur J Nutr (2016) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 人类; 1:1000; 图 6
赛默飞世尔 ACTG1抗体(Thermo Fisher, MA1-744)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6). Mol Med Rep (2015) ncbi
小鼠 单克隆(mAbGEa)
赛默飞世尔 ACTG1抗体(Fisher, MA1-744)被用于. Traffic (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 1:10,000; 图 5
赛默飞世尔 ACTG1抗体(分子探针, C4)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 5). Nat Commun (2015) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 图 1,2,3,4,5,6
赛默飞世尔 ACTG1抗体(neomarkers, ACTN05)被用于被用于免疫印迹在小鼠样本上 (图 1,2,3,4,5,6). Breast Cancer Res (2014) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类
赛默飞世尔 ACTG1抗体(NeoMarkers, ACTN05)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
小鼠 单克隆(MSA06 (HUC1-1))
  • 免疫组化-石蜡切片; 大西洋鲑鱼; 图 5a
赛默飞世尔 ACTG1抗体(Thermo Fisher Scientific, MS-1296-P)被用于被用于免疫组化-石蜡切片在大西洋鲑鱼样本上 (图 5a). J Fish Dis (2016) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; fruit fly ; 1:4000
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA5-11869)被用于被用于免疫印迹在fruit fly 样本上浓度为1:4000. Mech Dev (2014) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 犬; 1:2000
赛默飞世尔 ACTG1抗体(Thermo, MS-1295-P1)被用于被用于免疫印迹在犬样本上浓度为1:2000. PLoS ONE (2014) ncbi
小鼠 单克隆(ACTN05 (C4))
赛默飞世尔 ACTG1抗体(Thermo Fisher Scientific, MS-1295-P1ABX)被用于. Am J Pathol (2014) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 1:1000; 图 5
赛默飞世尔 ACTG1抗体(NeoMarkers, MS-1295-P1)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). J Cell Physiol (2014) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 图 1
赛默飞世尔 ACTG1抗体(Thermo Scientific, MS1295P1)被用于被用于免疫印迹在小鼠样本上 (图 1). Front Cell Infect Microbiol (2013) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠
赛默飞世尔 ACTG1抗体(Thermo Fisher, ACTN05)被用于被用于免疫印迹在小鼠样本上. Cancer Prev Res (Phila) (2014) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 人类
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA1-744)被用于被用于免疫印迹在人类样本上. Cell Signal (2014) ncbi
小鼠 单克隆(HHF35)
  • 免疫组化; 人类; 1:100; 表 1
赛默飞世尔 ACTG1抗体(Neomarker, HHF-35)被用于被用于免疫组化在人类样本上浓度为1:100 (表 1). Int J Surg Pathol (2014) ncbi
小鼠 单克隆(mAbGEa)
  • 免疫印迹; 非洲爪蛙
赛默飞世尔 ACTG1抗体(Thermo Scientific, MA1-744)被用于被用于免疫印迹在非洲爪蛙样本上. J Biol Chem (2013) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 图 3
赛默飞世尔 ACTG1抗体(Lab Vision, Ab-5)被用于被用于免疫印迹在人类样本上 (图 3). Exp Cell Res (2010) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 小鼠; 图 6
赛默飞世尔 ACTG1抗体(Neomarkers, ACTN05)被用于被用于免疫印迹在小鼠样本上 (图 6). PLoS ONE (2010) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 图 8
赛默飞世尔 ACTG1抗体(Neomarkers, ACTN05)被用于被用于免疫印迹在人类样本上 (图 8). Neuropathology (2009) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 人类; 图 4
赛默飞世尔 ACTG1抗体(Neomarkers, ACTN05)被用于被用于免疫印迹在人类样本上 (图 4). Mol Hum Reprod (2008) ncbi
小鼠 单克隆(ACTN05 (C4))
  • 免疫印迹; 大鼠; 1:1000
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 ACTG1抗体(LabVision, ACTN05)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 和 被用于免疫印迹在人类样本上浓度为1:1000. Brain (2007) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR19353-2)
  • 免疫印迹; 小鼠; 1:1000; 图 6a
艾博抗(上海)贸易有限公司 ACTG1抗体(Abcam, ab200046)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Redox Biol (2019) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(2A3)
  • proximity ligation assay; 人类; 图 s4
  • 免疫组化-石蜡切片; 人类; 图 1
  • 免疫细胞化学; 人类; 图 2
  • 免疫印迹; 人类; 图 2
伯乐(Bio-Rad)公司 ACTG1抗体(AbD Serotec, MCA5776GA)被用于被用于proximity ligation assay在人类样本上 (图 s4), 被用于免疫组化-石蜡切片在人类样本上 (图 1), 被用于免疫细胞化学在人类样本上 (图 2) 和 被用于免疫印迹在人类样本上 (图 2). Oncotarget (2015) ncbi
文章列表
  1. Hua X, Ge S, Zhang M, Mo F, Zhang L, Zhang J, et al. Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion. Front Immunol. 2021;12:706027 pubmed 出版商
  2. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed 出版商
  3. Fomicheva M, Macara I. Genome-wide CRISPR screen identifies noncanonical NF-κB signaling as a regulator of density-dependent proliferation. elife. 2020;9: pubmed 出版商
  4. Gurley J, Gmyrek G, McClellan M, Hargis E, Hauck S, Dozmorov M, et al. Neuroretinal-Derived Caveolin-1 Promotes Endotoxin-Induced Inflammation in the Murine Retina. Invest Ophthalmol Vis Sci. 2020;61:19 pubmed 出版商
  5. Zatulovskiy E, Zhang S, Berenson D, Topacio B, Skotheim J. Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division. Science. 2020;369:466-471 pubmed 出版商
  6. Beltran Camacho L, Jimenez Palomares M, Rojas Torres M, Sánchez Gomar I, Rosal Vela A, Eslava Alcon S, et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res Ther. 2020;11:106 pubmed 出版商
  7. Mallampalli R, Li X, Jang J, Kaminski T, Hoji A, Coon T, et al. Cigarette smoke exposure enhances transforming acidic coiled-coil-containing protein 2 turnover and thereby promotes emphysema. JCI Insight. 2020;5: pubmed 出版商
  8. Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue H, et al. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Cell Prolif. 2020;53:e12742 pubmed 出版商
  9. Singh V, Khalil M, De Benedetti A. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1. Cell Cycle. 2020;19:363-375 pubmed 出版商
  10. Chen W, Wang Q, Xu X, Saxton B, Tessema M, Leng S, et al. Vasorin/ATIA Promotes Cigarette Smoke-Induced Transformation of Human Bronchial Epithelial Cells by Suppressing Autophagy-Mediated Apoptosis. Transl Oncol. 2020;13:32-41 pubmed 出版商
  11. Zhang B, Chen H, Ouyang J, Xie Y, Chen L, Tan Q, et al. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect. Autophagy. 2019;:1-17 pubmed 出版商
  12. Fons N, Sundaram R, Breuer G, Peng S, McLean R, Kalathil A, et al. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nat Commun. 2019;10:3790 pubmed 出版商
  13. V gtle T, Sharma S, Mori J, Nagy Z, Semeniak D, Scandola C, et al. Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B. elife. 2019;8: pubmed 出版商
  14. Ni Z, Kuang L, Chen H, Xie Y, Zhang B, Ouyang J, et al. The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis. Cell Death Dis. 2019;10:522 pubmed 出版商
  15. Nortley R, Korte N, Izquierdo P, Hirunpattarasilp C, Mishra A, Jaunmuktane Z, et al. Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes. Science. 2019;: pubmed 出版商
  16. Zhao B, Du F, Xu P, Shu C, Sankaran B, Bell S, et al. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. Nature. 2019;: pubmed 出版商
  17. Li B, He J, Lv H, Liu Y, Lv X, Zhang C, et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. J Clin Invest. 2019;129:1167-1179 pubmed 出版商
  18. Li H, Feng J, Zhang Y, Feng J, Wang Q, Zhao S, et al. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway. Redox Biol. 2019;20:261-274 pubmed 出版商
  19. Nagasaki A, Kato Y, Meguro K, Yamagishi A, Nakamura C, Uyeda T. A genome editing vector that enables easy selection and identification of knockout cells. Plasmid. 2018;98:37-44 pubmed 出版商
  20. Rodríguez Baena F, Redondo García S, Peris Torres C, Martino Echarri E, Fernández Rodríguez R, Plaza Calonge M, et al. ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response. Sci Rep. 2018;8:13103 pubmed 出版商
  21. Urata S, Kenyon E, Nayak D, Cubitt B, Kurosaki Y, Yasuda J, et al. BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection. PLoS Pathog. 2018;14:e1007172 pubmed 出版商
  22. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed 出版商
  23. Reichenbach N, Delekate A, Breithausen B, Keppler K, Poll S, Schulte T, et al. P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model. J Exp Med. 2018;215:1649-1663 pubmed 出版商
  24. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed 出版商
  25. Li T, Zhao J. Knockdown of elF3a inhibits TGF??1?induced extracellular matrix protein expression in keloid fibroblasts. Mol Med Rep. 2018;17:4057-4061 pubmed 出版商
  26. Aguado L, Schmid S, May J, Sabin L, Panis M, Blanco Melo D, et al. RNase III nucleases from diverse kingdoms serve as antiviral effectors. Nature. 2017;547:114-117 pubmed 出版商
  27. Chen S, Wang Y, Zhang W, Dong M, Zhang J. Sclareolide enhances gemcitabine?induced cell death through mediating the NICD and Gli1 pathways in gemcitabine?resistant human pancreatic cancer. Mol Med Rep. 2017;15:1461-1470 pubmed 出版商
  28. Moradi M, Sivadasan R, Saal L, Lüningschrör P, Dombert B, Rathod R, et al. Differential roles of α-, β-, and γ-actin in axon growth and collateral branch formation in motoneurons. J Cell Biol. 2017;216:793-814 pubmed 出版商
  29. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed 出版商
  30. Mayrhofer M, Gourain V, Reischl M, Affaticati P, Jenett A, Joly J, et al. A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth. Dis Model Mech. 2017;10:15-28 pubmed 出版商
  31. Jørgensen L, Jepsen P, Boysen A, Dalgaard L, Hvid L, Ørtenblad N, et al. SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo. Am J Pathol. 2017;187:457-474 pubmed 出版商
  32. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed 出版商
  33. He M, Yuan H, Tan B, Bai R, Kim H, Bae S, et al. SIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi's sarcoma-associated herpesvirus transformed cells. Oncotarget. 2016;7:75698-75711 pubmed 出版商
  34. Sun K, Xu S, Chen J, Liu G, Shen X, Wu X. Atypical presentation of a gastric stromal tumor masquerading as a giant intraabdominal cyst: A case report. Oncol Lett. 2016;12:3018-3020 pubmed
  35. Romeo S, Conti A, Polito F, Tomasello C, Barresi V, La Torre D, et al. miRNA regulation of Sirtuin-1 expression in human astrocytoma. Oncol Lett. 2016;12:2992-2998 pubmed
  36. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed 出版商
  37. Zhao G, Zhu P, Renvoisé B, Maldonado Baez L, Park S, Blackstone C. Mammalian knock out cells reveal prominent roles for atlastin GTPases in ER network morphology. Exp Cell Res. 2016;349:32-44 pubmed 出版商
  38. Frolikova M, Sebkova N, Ded L, Dvorakova Hortova K. Characterization of CD46 and ?1 integrin dynamics during sperm acrosome reaction. Sci Rep. 2016;6:33714 pubmed 出版商
  39. Zhou S, Han Q, Wang R, Li X, Wang Q, Wang H, et al. PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress. Oncol Lett. 2016;12:2217-2221 pubmed
  40. Sousa A, Rei M, Freitas R, Ricardo S, Caffrey T, David L, et al. Effect of MUC1/?-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells. Oncol Lett. 2016;12:1811-1817 pubmed
  41. Li J, Yang Z, Chen Z, Bao Y, Zhang H, Fang X, et al. ATF3 suppresses ESCC via downregulation of ID1. Oncol Lett. 2016;12:1642-1648 pubmed
  42. Abraham K, Chan J, Salvi J, Ho B, Hall A, Vidya E, et al. Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA-DNA hybrids. Nucleic Acids Res. 2016;44:8870-8884 pubmed
  43. Weikel K, Cacicedo J, Ruderman N, Ido Y. Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells. Biosci Rep. 2016;36: pubmed 出版商
  44. Bercovich Kinori A, Tai J, Gelbart I, Shitrit A, Ben Moshe S, Drori Y, et al. A systematic view on influenza induced host shutoff. elife. 2016;5: pubmed 出版商
  45. Wang X, Shaw D, Hammond H, Sutterwala F, Rayamajhi M, Shirey K, et al. The Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome Activation. PLoS Pathog. 2016;12:e1005803 pubmed 出版商
  46. Fritzen R, Delbos F, De Smet A, Palancade B, Canman C, Aoufouchi S, et al. A single aspartate mutation in the conserved catalytic site of Rev3L generates a hypomorphic phenotype in vivo and in vitro. DNA Repair (Amst). 2016;46:37-46 pubmed 出版商
  47. Das S, Rehman I, Ghosh A, Sengupta S, Majumdar P, Jana B, et al. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells. Nucleic Acids Res. 2016;44:8363-75 pubmed 出版商
  48. Yang X, Zhou X, Tone P, Durkin M, Popescu N. Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications. Oncol Lett. 2016;12:1591-1596 pubmed
  49. Jin Z, Yan W, Jin H, Ge C, Xu Y. Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-?B and PI3K/Akt signaling pathways. Oncol Lett. 2016;12:971-976 pubmed
  50. Geng J, Li J, Huang T, Zhao K, Chen Q, Guo W, et al. A novel manganese complex selectively induces malignant glioma cell death by targeting mitochondria. Mol Med Rep. 2016;14:1970-8 pubmed 出版商
  51. He Z, Forest F, Gain P, Rageade D, Bernard A, Acquart S, et al. 3D map of the human corneal endothelial cell. Sci Rep. 2016;6:29047 pubmed 出版商
  52. Espinoza I, Sakiyama M, Ma T, Fair L, Zhou X, Hassan M, et al. Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells. Front Oncol. 2016;6:144 pubmed 出版商
  53. Ambrosi C, Ren C, Spagnol G, Cavin G, CONE A, Grintsevich E, et al. Connexin43 Forms Supramolecular Complexes through Non-Overlapping Binding Sites for Drebrin, Tubulin, and ZO-1. PLoS ONE. 2016;11:e0157073 pubmed 出版商
  54. Wang T, Pan D, Zhou Z, You Y, Jiang C, Zhao X, et al. Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut. PLoS Pathog. 2016;12:e1005662 pubmed 出版商
  55. Ikeuchi M, Fukumoto Y, Honda T, Kuga T, Saito Y, Yamaguchi N, et al. v-Src Causes Chromosome Bridges in a Caffeine-Sensitive Manner by Generating DNA Damage. Int J Mol Sci. 2016;17: pubmed 出版商
  56. Stampfl H, Fritz M, Dal Santo S, Jonak C. The GSK3/Shaggy-Like Kinase ASKα Contributes to Pattern-Triggered Immunity. Plant Physiol. 2016;171:1366-77 pubmed 出版商
  57. Freeman S, Christian S, Austin P, Iu I, Graves M, Huang L, et al. Applied stretch initiates directional invasion through the action of Rap1 GTPase as a tension sensor. J Cell Sci. 2017;130:152-163 pubmed 出版商
  58. Speer S, Li Z, Buta S, Payelle Brogard B, Qian L, Vigant F, et al. ISG15 deficiency and increased viral resistance in humans but not mice. Nat Commun. 2016;7:11496 pubmed 出版商
  59. Chen Z, Mei Y, Lei H, Tian R, Ni N, Han F, et al. LYTAK1, a TAK1 inhibitor, suppresses proliferation and epithelial?mesenchymal transition in retinal pigment epithelium cells. Mol Med Rep. 2016;14:145-50 pubmed 出版商
  60. Yu P, Ji L, Lee K, Yu M, He C, Ambati S, et al. Subsets of Visceral Adipose Tissue Nuclei with Distinct Levels of 5-Hydroxymethylcytosine. PLoS ONE. 2016;11:e0154949 pubmed 出版商
  61. Hsu C, Hsu C, Hsueh C, Wang C, Wu Y, Wu C, et al. Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma. Mol Cell Proteomics. 2016;15:2396-410 pubmed 出版商
  62. Passalacqua K, Charbonneau M, Donato N, Showalter H, Sun D, Wen B, et al. Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Antimicrob Agents Chemother. 2016;60:4183-96 pubmed 出版商
  63. Fajardo V, Smith I, Bombardier E, Chambers P, Quadrilatero J, Tupling A. Diaphragm assessment in mice overexpressing phospholamban in slow-twitch type I muscle fibers. Brain Behav. 2016;6:e00470 pubmed 出版商
  64. Dinger K, Kasper P, Hucklenbruch Rother E, Vohlen C, Jobst E, Janoschek R, et al. Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice. Sci Rep. 2016;6:24168 pubmed 出版商
  65. Kruzliak P, Hare D, Sabaka P, Delev D, Gaspar L, Rodrigo L, et al. Evidence for CD34/SMA positive cells in the left main coronary artery in atherogenesis. Acta Histochem. 2016;118:413-7 pubmed 出版商
  66. Walia M, Ho P, Taylor S, Ng A, Gupte A, Chalk A, et al. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. elife. 2016;5: pubmed 出版商
  67. Miao Y, Han X, Zheng L, Xie Y, Mu Y, Yates J, et al. Fimbrin phosphorylation by metaphase Cdk1 regulates actin cable dynamics in budding yeast. Nat Commun. 2016;7:11265 pubmed 出版商
  68. Körber N, Stein V. In vivo imaging demonstrates dendritic spine stabilization by SynCAM 1. Sci Rep. 2016;6:24241 pubmed 出版商
  69. Wang X, Shaw D, Sakhon O, Snyder G, Sundberg E, Santambrogio L, et al. The Tick Protein Sialostatin L2 Binds to Annexin A2 and Inhibits NLRC4-Mediated Inflammasome Activation. Infect Immun. 2016;84:1796-1805 pubmed 出版商
  70. Negis Y, Karabay A. Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity. Biofactors. 2016;42:358-67 pubmed 出版商
  71. Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed 出版商
  72. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed 出版商
  73. Liu L, Bai Z, Ma X, Wang T, Yang Y, Zhang Z. Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin. Exp Ther Med. 2016;11:846-852 pubmed
  74. Jennewein L, Ronellenfitsch M, Antonietti P, Ilina E, Jung J, Stadel D, et al. Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas. Oncotarget. 2016;7:20016-32 pubmed 出版商
  75. Wang X, Chen L, Liu J, Yan T, Wu G, Xia Y, et al. In vivo treatment of rat arterial adventitia with interleukin‑1β induces intimal proliferation via the JAK2/STAT3 signaling pathway. Mol Med Rep. 2016;13:3451-8 pubmed 出版商
  76. Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. Mol Cancer Ther. 2016;15:628-39 pubmed 出版商
  77. Bach F, Zhang Y, Miranda Bedate A, Verdonschot L, Bergknut N, Creemers L, et al. Increased caveolin-1 in intervertebral disc degeneration facilitates repair. Arthritis Res Ther. 2016;18:59 pubmed 出版商
  78. Liu L, Tong Q, Liu S, Cui J, Zhang Q, Sun W, et al. ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer. PLoS ONE. 2016;11:e0148774 pubmed 出版商
  79. Malecova B, Dall Agnese A, Madaro L, Gatto S, Coutinho Toto P, Albini S, et al. TBP/TFIID-dependent activation of MyoD target genes in skeletal muscle cells. elife. 2016;5: pubmed 出版商
  80. Kim J, Kim E, Lee B, Min J, Song D, Lim J, et al. The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells. Int J Mol Med. 2016;37:649-58 pubmed 出版商
  81. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  82. Pivonello C, Negri M, De Martino M, Napolitano M, De Angelis C, Provvisiero D, et al. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma. Oncotarget. 2016;7:9718-31 pubmed 出版商
  83. Umazume T, Thomas W, Campbell S, Aluri H, Thotakura S, Zoukhri D, et al. Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells. Invest Ophthalmol Vis Sci. 2015;56:8392-402 pubmed 出版商
  84. Suzuki Y, Chin W, Han Q, Ichiyama K, Lee C, Eyo Z, et al. Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication. PLoS Pathog. 2016;12:e1005357 pubmed 出版商
  85. Hrstka R, Bouchalova P, Michalová E, Matoulkova E, Muller P, Coates P, et al. AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway. Mol Oncol. 2016;10:652-62 pubmed 出版商
  86. Tagliatti E, Fadda M, Falace A, Benfenati F, Fassio A. Arf6 regulates the cycling and the readily releasable pool of synaptic vesicles at hippocampal synapse. elife. 2016;5: pubmed 出版商
  87. Creedon H, Balderstone L, Muir M, Balla J, Gómez Cuadrado L, Tracey N, et al. Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer. Dis Model Mech. 2016;9:131-40 pubmed 出版商
  88. Wang Y, Hou H, Li M, Yang Y, Sun L. Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway. Mol Med Rep. 2016;13:1141-6 pubmed 出版商
  89. Marazita M, Dugour A, Marquioni Ramella M, Figueroa J, Suburo A. Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: Implications for Age-related Macular Degeneration. Redox Biol. 2016;7:78-87 pubmed 出版商
  90. Brai E, Marathe S, Astori S, Fredj N, Perry E, Lamy C, et al. Notch1 Regulates Hippocampal Plasticity Through Interaction with the Reelin Pathway, Glutamatergic Transmission and CREB Signaling. Front Cell Neurosci. 2015;9:447 pubmed 出版商
  91. Leshchyns ka I, Liew H, Shepherd C, Halliday G, Stevens C, Ke Y, et al. Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease. Nat Commun. 2015;6:8836 pubmed 出版商
  92. Furlan S, Mosole S, Murgia M, Nagaraj N, Argenton F, Volpe P, et al. Calsequestrins in skeletal and cardiac muscle from adult Danio rerio. J Muscle Res Cell Motil. 2016;37:27-39 pubmed 出版商
  93. Cao J, Zhang X, Wang Q, Qiu G, Hou C, Wang J, et al. Smad4 represses the generation of memory-precursor effector T cells but is required for the differentiation of central memory T cells. Cell Death Dis. 2015;6:e1984 pubmed 出版商
  94. Wang W, Liu H, Dai X, Fang S, Wang X, Zhang Y, et al. p53/PUMA expression in human pulmonary fibroblasts mediates cell activation and migration in silicosis. Sci Rep. 2015;5:16900 pubmed 出版商
  95. Hu Z, Hu J, Shen W, Kraemer F, Azhar S. A Novel Role of Salt-Inducible Kinase 1 (SIK1) in the Post-Translational Regulation of Scavenger Receptor Class B Type 1 Activity. Biochemistry. 2015;54:6917-30 pubmed 出版商
  96. Hu X, Garcia C, Fazli L, Gleave M, Vitek M, Jansen M, et al. Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis. Sci Rep. 2015;5:15182 pubmed 出版商
  97. Alnasser H, Guan Q, Zhang F, Gleave M, Nguan C, Du C. Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells. Am J Physiol Renal Physiol. 2016;310:F160-73 pubmed 出版商
  98. Lohberger B, Leithner A, Stuendl N, Kaltenegger H, Kullich W, Steinecker Frohnwieser B. Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation. BMC Cancer. 2015;15:891 pubmed 出版商
  99. Osmanagic Myers S, Rus S, Wolfram M, Brunner D, Goldmann W, Bonakdar N, et al. Plectin reinforces vascular integrity by mediating crosstalk between the vimentin and the actin networks. J Cell Sci. 2015;128:4138-50 pubmed 出版商
  100. Antonucci L, Fagman J, Kim J, Todoric J, Gukovsky I, Mackey M, et al. Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc Natl Acad Sci U S A. 2015;112:E6166-74 pubmed 出版商
  101. Oh Y, Park H, Shin J, Lee J, Park H, Kho D, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698 pubmed 出版商
  102. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed 出版商
  103. Kizuka Y, Nakano M, Kitazume S, Saito T, Saido T, Taniguchi N. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions. Biochem J. 2016;473:21-30 pubmed 出版商
  104. Zhang W, Pelicano H, Yin R, Zeng J, Wen T, Ding L, et al. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms. Mol Med Rep. 2015;12:7374-88 pubmed 出版商
  105. Takeda S, Wegmann S, Cho H, DeVos S, Commins C, Roe A, et al. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain. Nat Commun. 2015;6:8490 pubmed 出版商
  106. Liu F, Hon G, Villa G, Turner K, Ikegami S, Yang H, et al. EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell. 2015;60:307-18 pubmed 出版商
  107. Li Z, Hao Q, Luo J, Xiong J, Zhang S, Wang T, et al. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. Oncogene. 2016;35:2902-12 pubmed 出版商
  108. Woolery K, Mohamed M, Linger R, Dobrinski K, Roman J, Kruk P. BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells. Biomed Res Int. 2015;2015:652017 pubmed 出版商
  109. Yao J, Zheng K, Zhang X. Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury. Mol Med Rep. 2015;12:6591-7 pubmed 出版商
  110. Archibald A, Al Masri M, Liew Spilger A, McCaffrey L. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling. Mol Biol Cell. 2015;26:3578-95 pubmed 出版商
  111. Morancho B, Martínez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed 出版商
  112. Khan I, Zakaria M, Kumar M, Mani P, Chattopadhyay P, Sarkar D, et al. A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]. J Transl Med. 2015;13:254 pubmed 出版商
  113. Xie X, Hsu F, Gao X, Xu W, Ni J, Xing Y, et al. CDK8-Cyclin C Mediates Nutritional Regulation of Developmental Transitions through the Ecdysone Receptor in Drosophila. PLoS Biol. 2015;13:e1002207 pubmed 出版商
  114. DubiÅ„ska Magiera M, Chmielewska M, KozioÅ‚ K, Machowska M, Hutchison C, Goldberg M, et al. Xenopus LAP2β protein knockdown affects location of lamin B and nucleoporins and has effect on assembly of cell nucleus and cell viability. Protoplasma. 2016;253:943-56 pubmed 出版商
  115. Chung D, Chan J, Strecker J, Zhang W, Ebrahimi Ardebili S, Lu T, et al. Perinuclear tethers license telomeric DSBs for a broad kinesin- and NPC-dependent DNA repair process. Nat Commun. 2015;6:7742 pubmed 出版商
  116. Zhao L, Tang M, Hu Z, Yan B, Pi W, Li Z, et al. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma. Oncotarget. 2015;6:15995-6018 pubmed
  117. Sloan E, Tatham M, Groslambert M, Glass M, Orr A, Hay R, et al. Analysis of the SUMO2 Proteome during HSV-1 Infection. PLoS Pathog. 2015;11:e1005059 pubmed 出版商
  118. Li W, Qiu Y, Zhang H, Tian X, Fang W. P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway. PLoS ONE. 2015;10:e0133165 pubmed 出版商
  119. Jones M, Hu W, Litthauer S, Lagarias J, Harmer S. A Constitutively Active Allele of Phytochrome B Maintains Circadian Robustness in the Absence of Light. Plant Physiol. 2015;169:814-25 pubmed 出版商
  120. Lee J, Kim H, Han J, Kim Y, Son C. Anti-fatigue effect of Myelophil in a chronic forced exercise mouse model. Eur J Pharmacol. 2015;764:100-8 pubmed 出版商
  121. Liu R, Fan M, Candas D, Qin L, Zhang X, Eldridge A, et al. CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance. Mol Cancer Ther. 2015;14:2090-102 pubmed 出版商
  122. Breslin C, Hornyak P, Ridley A, Rulten S, Hanzlikova H, Oliver A, et al. The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function. Nucleic Acids Res. 2015;43:6934-44 pubmed 出版商
  123. Nadeau M, Rico C, Tsoi M, Vivancos M, Filimon S, Paquet M, et al. Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells. BMC Cancer. 2015;15:479 pubmed 出版商
  124. Mercer J, Argus J, Crabtree D, KEENAN M, Wilks M, Chi J, et al. Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis. PLoS ONE. 2015;10:e0129776 pubmed 出版商
  125. Masuda Y, Takahashi H, Hatakeyama S. TRIM29 regulates the p63-mediated pathway in cervical cancer cells. Biochim Biophys Acta. 2015;1853:2296-305 pubmed 出版商
  126. Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, et al. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts. J Transl Med. 2015;13:191 pubmed 出版商
  127. Zhang T, Zhou Y, Qi S, Wang Z, Qian W, Ouyang Y, et al. Nuf2 is required for chromosome segregation during mouse oocyte meiotic maturation. Cell Cycle. 2015;14:2701-10 pubmed 出版商
  128. Cui J, Bai X, Sun X, Cai G, Hong Q, Ding R, et al. Rapamycin protects against gentamicin-induced acute kidney injury via autophagy in mini-pig models. Sci Rep. 2015;5:11256 pubmed 出版商
  129. Barr A, Bakal C. A sensitised RNAi screen reveals a ch-TOG genetic interaction network required for spindle assembly. Sci Rep. 2015;5:10564 pubmed 出版商
  130. Andrade L. Evidence for changes in beta- and gamma-actin proportions during inner ear hair cell life. Cytoskeleton (Hoboken). 2015;72:282-91 pubmed 出版商
  131. Dugina V, Khromova N, Rybko V, Blizniukov O, Shagieva G, Chaponnier C, et al. Tumor promotion by γ and suppression by β non-muscle actin isoforms. Oncotarget. 2015;6:14556-71 pubmed
  132. Pan D, Jiang C, Ma Z, Blonska M, You M, Lin X. MALT1 is required for EGFR-induced NF-?B activation and contributes to EGFR-driven lung cancer progression. Oncogene. 2016;35:919-28 pubmed 出版商
  133. Kumar P, Gullberg U, Olsson I, Ajore R. Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. PLoS ONE. 2015;10:e0123725 pubmed 出版商
  134. Formisano L, Guida N, Valsecchi V, Cantile M, Cuomo O, Vinciguerra A, et al. Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism. J Neurosci. 2015;35:7332-48 pubmed 出版商
  135. Mahale S, Bharate S, Manda S, Joshi P, Jenkins P, Vishwakarma R, et al. Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. Cell Death Dis. 2015;6:e1743 pubmed 出版商
  136. Peiris Pagès M, Sotgia F, Lisanti M. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells. Oncotarget. 2015;6:10728-45 pubmed
  137. Randles M, Woolf A, Huang J, Byron A, Humphries J, Price K, et al. Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization. J Am Soc Nephrol. 2015;26:3021-34 pubmed 出版商
  138. Berkovits B, Mayr C. Alternative 3' UTRs act as scaffolds to regulate membrane protein localization. Nature. 2015;522:363-7 pubmed 出版商
  139. Chung J, Bauer D, Ghamari A, Nizzi C, Deck K, Kingsley P, et al. The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability. Sci Signal. 2015;8:ra34 pubmed 出版商
  140. Zhang X, Liang D, Chi Z, Chu Q, Zhao C, Ma R, et al. Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells. Int J Mol Med. 2015;35:1747-54 pubmed 出版商
  141. Pardo F, Silva L, Sáez T, Salsoso R, Gutiérrez J, Sanhueza C, et al. Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond). 2015;39:1264-73 pubmed 出版商
  142. Chien P, Lin C, Hsiao L, Yang C. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol Cell Endocrinol. 2015;409:59-72 pubmed 出版商
  143. Hong S, Lee J, Lee J, Lee H, Kim H, Lee S, et al. The traditional drug Gongjin-Dan ameliorates chronic fatigue in a forced-stress mouse exercise model. J Ethnopharmacol. 2015;168:268-78 pubmed 出版商
  144. Gu Q, Yu D, Hu Z, Liu X, Yang Y, Luo Y, et al. miR-26a and miR-384-5p are required for LTP maintenance and spine enlargement. Nat Commun. 2015;6:6789 pubmed 出版商
  145. Simões A, Pereira D, Gomes S, Brito H, Carvalho T, French A, et al. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. Cell Death Dis. 2015;6:e1718 pubmed 出版商
  146. Okatsu K, Koyano F, Kimura M, Kosako H, Saeki Y, Tanaka K, et al. Phosphorylated ubiquitin chain is the genuine Parkin receptor. J Cell Biol. 2015;209:111-28 pubmed 出版商
  147. Amrutkar M, Cansby E, Chursa U, Nuñez Durán E, Chanclón B, StÃ¥hlman M, et al. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model. Diabetes. 2015;64:2791-804 pubmed 出版商
  148. Bergamo P, Palmieri G, Cocca E, Ferrandino I, Gogliettino M, Monaco A, et al. Adaptive response activated by dietary cis9, trans11 conjugated linoleic acid prevents distinct signs of gliadin-induced enteropathy in mice. Eur J Nutr. 2016;55:729-740 pubmed 出版商
  149. Lee S, Chang J, Wu J, Sheu D. Antineoplastic effect of a novel chemopreventive agent, neokestose, on the Caco-2 cell line via inhibition of expression of nuclear factor-κB and cyclooxygenase-2. Mol Med Rep. 2015;12:1114-8 pubmed 出版商
  150. Majumdar T, Chattopadhyay S, Ozhegov E, Dhar J, Goswami R, Sen G, et al. Induction of interferon-stimulated genes by IRF3 promotes replication of Toxoplasma gondii. PLoS Pathog. 2015;11:e1004779 pubmed 出版商
  151. Yazlovitskaya E, Tseng H, Viquez O, Tu T, Mernaugh G, McKee K, et al. Integrin α3β1 regulates kidney collecting duct development via TRAF6-dependent K63-linked polyubiquitination of Akt. Mol Biol Cell. 2015;26:1857-74 pubmed 出版商
  152. Jamison S, Lin Y, Lin W. Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A. PLoS ONE. 2015;10:e0120252 pubmed 出版商
  153. Dicay M, Hirota C, Ronaghan N, Peplowski M, Zaheer R, Carati C, et al. Interferon-γ suppresses intestinal epithelial aquaporin-1 expression via Janus kinase and STAT3 activation. PLoS ONE. 2015;10:e0118713 pubmed 出版商
  154. Seo H, Woo J, Shin Y, Ko S. Identification of biomarkers regulated by rexinoids (LGD1069, LG100268 and Ro25-7386) in human breast cells using Affymetrix microarray. Mol Med Rep. 2015;12:800-18 pubmed 出版商
  155. Yang Y, Deng Q, Feng X, Sun J. Use of the disulfiram/copper complex for breast cancer chemoprevention in MMTV-erbB2 transgenic mice. Mol Med Rep. 2015;12:746-52 pubmed 出版商
  156. Pedro J, Wei Y, Sica V, Maiuri M, Zou Z, Kroemer G, et al. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy. 2015;11:452-9 pubmed 出版商
  157. Yang L, Liu L, Xu Z, Liao W, Feng D, Dong X, et al. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma. Oncotarget. 2015;6:5804-17 pubmed
  158. Polletta L, Vernucci E, Carnevale I, Arcangeli T, Rotili D, Palmerio S, et al. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy. 2015;11:253-70 pubmed 出版商
  159. Lin S, Huang S, Kuo H, Chen C, Ma Y, Chu T, et al. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway. Mar Drugs. 2015;13:861-78 pubmed 出版商
  160. Bobba A, Amadoro G, La Piana G, Petragallo V, Calissano P, Atlante A. Glucose-6-phosphate tips the balance in modulating apoptosis in cerebellar granule cells. FEBS Lett. 2015;589:651-8 pubmed 出版商
  161. Gibbs Seymour I, Markiewicz E, Bekker Jensen S, Mailand N, Hutchison C. Lamin A/C-dependent interaction with 53BP1 promotes cellular responses to DNA damage. Aging Cell. 2015;14:162-9 pubmed 出版商
  162. Feliciano D, Tolsma T, Farrell K, Aradi A, Di Pietro S. A second Las17 monomeric actin-binding motif functions in Arp2/3-dependent actin polymerization during endocytosis. Traffic. 2015;16:379-97 pubmed 出版商
  163. Amrutkar M, Cansby E, Nuñez Durán E, Pirazzi C, StÃ¥hlman M, Stenfeldt E, et al. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. FASEB J. 2015;29:1564-76 pubmed 出版商
  164. Xue T, Wei L, Zha D, Qiao L, Lu L, Chen F, et al. Exposure to acoustic stimuli promotes the development and differentiation of neural stem cells from the cochlear nuclei through the clusterin pathway. Int J Mol Med. 2015;35:637-44 pubmed 出版商
  165. Miyata M, Lee J, Susuki Miyata S, Wang W, Xu H, Kai H, et al. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. Nat Commun. 2015;6:6062 pubmed 出版商
  166. Matsuda Y, Kobayashi Ishihara M, Fujikawa D, Ishida T, Watanabe T, Yamagishi M. Epigenetic heterogeneity in HIV-1 latency establishment. Sci Rep. 2015;5:7701 pubmed 出版商
  167. Xue C, Zhang J, Lv Z, Liu H, Huang C, Yang J, et al. Angiotensin II promotes differentiation of mouse c-kit-positive cardiac stem cells into pacemaker-like cells. Mol Med Rep. 2015;11:3249-58 pubmed 出版商
  168. Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794 pubmed 出版商
  169. Chen J, Wang Z, Xu D, Liu Y, Gao Y. Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion. Mol Med Rep. 2015;11:2882-8 pubmed 出版商
  170. Izzo F, Mercogliano F, Venturutti L, Tkach M, Inurrigarro G, Schillaci R, et al. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Res. 2014;16:491 pubmed 出版商
  171. Kim H, Li A, Ahn S, Song H, Zhang W. Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity. Sci Rep. 2014;4:7330 pubmed 出版商
  172. Colman J, Laureano D, Reis T, Krolow R, Dalmaz C, Benetti C, et al. Variations in the neonatal environment modulate adult behavioral and brain responses to palatable food withdrawal in adult female rats. Int J Dev Neurosci. 2015;40:70-5 pubmed 出版商
  173. Giovannini C, Minguzzi M, Baglioni M, Fornari F, Giannone F, Ravaioli M, et al. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Oncotarget. 2014;5:10607-20 pubmed
  174. Roufayel R, Johnston D, Mosser D. The elimination of miR-23a in heat-stressed cells promotes NOXA-induced cell death and is prevented by HSP70. Cell Death Dis. 2014;5:e1546 pubmed 出版商
  175. Dalum A, Tangen R, Falk K, Hordvik I, Rosenlund G, Torstensen B, et al. Coronary changes in the Atlantic salmon Salmo salar L: characterization and impact of dietary fatty acid compositions. J Fish Dis. 2016;39:41-54 pubmed 出版商
  176. Lan N, Luo G, Yang X, Cheng Y, Zhang Y, Wang X, et al. 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS ONE. 2014;9:e111599 pubmed 出版商
  177. Bantikassegn A, Song X, Politi K. Isolation of epithelial, endothelial, and immune cells from lungs of transgenic mice with oncogene-induced lung adenocarcinomas. Am J Respir Cell Mol Biol. 2015;52:409-17 pubmed 出版商
  178. Dammer E, Lee A, Duong D, Gearing M, Lah J, Levey A, et al. Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015;15:508-519 pubmed 出版商
  179. Jia J, Hu Z, Nordman J, Li Z. The schizophrenia susceptibility gene dysbindin regulates dendritic spine dynamics. J Neurosci. 2014;34:13725-36 pubmed 出版商
  180. Bernard Marissal N, Sunyach C, Marissal T, Raoul C, Pettmann B. Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice. Neurobiol Dis. 2015;73:130-6 pubmed 出版商
  181. Portella A, Silveira P, Laureano D, Cardoso S, Bittencourt V, Noschang C, et al. Litter size reduction alters insulin signaling in the ventral tegmental area and influences dopamine-related behaviors in adult rats. Behav Brain Res. 2015;278:66-73 pubmed 出版商
  182. Ni W, Qiao J, Hu S, Zhao X, Regouski M, Yang M, et al. Efficient gene knockout in goats using CRISPR/Cas9 system. PLoS ONE. 2014;9:e106718 pubmed 出版商
  183. Torsvik J, Johansson B, Dalva M, Marie M, Fjeld K, Johansson S, et al. Endocytosis of secreted carboxyl ester lipase in a syndrome of diabetes and pancreatic exocrine dysfunction. J Biol Chem. 2014;289:29097-111 pubmed 出版商
  184. Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE. 2014;9:e104771 pubmed 出版商
  185. Zhang X, Ma W, Cui J, Yao H, Zhou H, Ge Y, et al. Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia. Oncogene. 2015;34:3000-10 pubmed 出版商
  186. Zheng Y, Hsu F, Xu W, Xie X, Ren X, Gao X, et al. A developmental genetic analysis of the lysine demethylase KDM2 mutations in Drosophila melanogaster. Mech Dev. 2014;133:36-53 pubmed 出版商
  187. Doceul V, Chauveau E, Lara E, Breard E, Sailleau C, Zientara S, et al. Dual modulation of type I interferon response by bluetongue virus. J Virol. 2014;88:10792-802 pubmed 出版商
  188. Cansby E, Nerstedt A, Amrutkar M, Durán E, Smith U, Mahlapuu M. Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained. Mol Cell Endocrinol. 2014;393:143-51 pubmed 出版商
  189. Hu Q, Dong J, DU H, Zhang D, Ren H, Ma M, et al. Constitutive G?i coupling activity of very large G protein-coupled receptor 1 (VLGR1) and its regulation by PDZD7 protein. J Biol Chem. 2014;289:24215-25 pubmed 出版商
  190. Howell K, Pillai A. Effects of prenatal hypoxia on schizophrenia-related phenotypes in heterozygous reeler mice: a gene × environment interaction study. Eur Neuropsychopharmacol. 2014;24:1324-36 pubmed 出版商
  191. Gracanin A, Timmermans Sprang E, van Wolferen M, Rao N, Grizelj J, Vince S, et al. Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression. PLoS ONE. 2014;9:e98698 pubmed 出版商
  192. Verstegen A, Tagliatti E, Lignani G, Marte A, Stolero T, Atias M, et al. Phosphorylation of synapsin I by cyclin-dependent kinase-5 sets the ratio between the resting and recycling pools of synaptic vesicles at hippocampal synapses. J Neurosci. 2014;34:7266-80 pubmed 出版商
  193. Yuan B, Wan P, Chu D, Nie J, Cao Y, Luo W, et al. A cardiomyocyte-specific Wdr1 knockout demonstrates essential functional roles for actin disassembly during myocardial growth and maintenance in mice. Am J Pathol. 2014;184:1967-80 pubmed 出版商
  194. Cheng Y, Cao A, Zheng J, Wang H, Sun Y, Liu C, et al. Airway hyperresponsiveness induced by repeated esophageal infusion of HCl in guinea pigs. Am J Respir Cell Mol Biol. 2014;51:701-8 pubmed 出版商
  195. Bach F, Rutten K, Hendriks K, Riemers F, Cornelissen P, de Bruin A, et al. The paracrine feedback loop between vitamin D? (1,25(OH)?D?) and PTHrP in prehypertrophic chondrocytes. J Cell Physiol. 2014;229:1999-2014 pubmed 出版商
  196. Quintin J, Le Péron C, Palierne G, Bizot M, Cunha S, Sérandour A, et al. Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities. Mol Cell Biol. 2014;34:2418-36 pubmed 出版商
  197. Schroder W, Major L, Le T, Gardner J, Sweet M, Janciauskiene S, et al. Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis. Cancer Med. 2014;3:500-13 pubmed 出版商
  198. Carloni S, Albertini M, Galluzzi L, Buonocore G, Proietti F, Balduini W. Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia-ischemia: role of protein synthesis and autophagic pathways. Exp Neurol. 2014;255:103-12 pubmed 出版商
  199. Ohshima J, Lee Y, Sasai M, Saitoh T, Su Ma J, Kamiyama N, et al. Role of mouse and human autophagy proteins in IFN-?-induced cell-autonomous responses against Toxoplasma gondii. J Immunol. 2014;192:3328-35 pubmed 出版商
  200. Qi M, Zhang J, Zeng W, Chen X. DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner. Biochim Biophys Acta. 2014;1839:62-9 pubmed 出版商
  201. Bronner D, O Riordan M, He Y. Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis. Front Cell Infect Microbiol. 2013;3:83 pubmed 出版商
  202. Bi J, Wang R, Zhang Y, Han X, Ampah K, Liu W, et al. Identification of nucleolin as a lipid-raft-dependent ?1-integrin-interacting protein in A375 cell migration. Mol Cells. 2013;36:507-17 pubmed 出版商
  203. Hasty P, Livi C, Dodds S, Jones D, Strong R, Javors M, et al. eRapa restores a normal life span in a FAP mouse model. Cancer Prev Res (Phila). 2014;7:169-78 pubmed 出版商
  204. Sadakata T, Kakegawa W, Shinoda Y, Hosono M, Katoh Semba R, Sekine Y, et al. CAPS1 deficiency perturbs dense-core vesicle trafficking and Golgi structure and reduces presynaptic release probability in the mouse brain. J Neurosci. 2013;33:17326-34 pubmed 出版商
  205. Sollome J, Thavathiru E, Camenisch T, Vaillancourt R. HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4). Cell Signal. 2014;26:70-82 pubmed 出版商
  206. Lee P, Yau D, Lau P, Chan J. Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess. Int J Surg Pathol. 2014;22:286-90 pubmed 出版商
  207. Chandra S, Priyadarshini R, Madhavan V, Tikoo S, Hussain M, Mudgal R, et al. Enhancement of c-Myc degradation by BLM helicase leads to delayed tumor initiation. J Cell Sci. 2013;126:3782-95 pubmed 出版商
  208. Henderson Y, Toro Serra R, Chen Y, Ryu J, Frederick M, Zhou G, et al. Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck. 2014;36:375-84 pubmed 出版商
  209. Pantaleo M, Astolfi A, Urbini M, Nannini M, Paterini P, Indio V, et al. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. Eur J Hum Genet. 2014;22:32-9 pubmed 出版商
  210. Murata Y, Constantine Paton M. Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway. J Neurosci. 2013;33:5040-52 pubmed 出版商
  211. Xu J, Deng X, Tang M, Li L, Xiao L, Yang L, et al. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma. PLoS ONE. 2013;8:e56114 pubmed 出版商
  212. McCoy F, Darbandi R, Chen S, Eckard L, Dodd K, Jones K, et al. Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extracts. J Biol Chem. 2013;288:8838-48 pubmed 出版商
  213. Sánchez Alvarez R, Martinez Outschoorn U, Lin Z, Lamb R, Hulit J, Howell A, et al. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle. 2013;12:289-301 pubmed 出版商
  214. Peddigari S, Li P, Rabe J, Martin S. hnRNPL and nucleolin bind LINE-1 RNA and function as host factors to modulate retrotransposition. Nucleic Acids Res. 2013;41:575-85 pubmed 出版商
  215. Chen Y, Sundvik M, Rozov S, Priyadarshini M, Panula P. MANF regulates dopaminergic neuron development in larval zebrafish. Dev Biol. 2012;370:237-49 pubmed 出版商
  216. Wakabayashi T, Kosaka J, Mori T, Yamada H. Prolonged expression of Puma in cholinergic amacrine cells during the development of rat retina. J Histochem Cytochem. 2012;60:777-88 pubmed
  217. Tai C, Shen S, Lee W, Liao C, Deng W, Chiou H, et al. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res. 2010;316:2969-81 pubmed 出版商
  218. Kurz A, Double K, Lastres Becker I, Tozzi A, Tantucci M, Bockhart V, et al. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS ONE. 2010;5:e11464 pubmed 出版商
  219. Polo M, Arnoni M, Riggio M, Wargon V, Lanari C, Novaro V. Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice. PLoS ONE. 2010;5:e10786 pubmed 出版商
  220. Holthouse D, Dallas P, Ford J, Fabian V, Murch A, Watson M, et al. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines. Neuropathology. 2009;29:398-409 pubmed 出版商
  221. Marín Briggiler C, Veiga M, Matos M, Echeverría M, Furlong L, Vazquez Levin M. Expression of epithelial cadherin in the human male reproductive tract and gametes and evidence of its participation in fertilization. Mol Hum Reprod. 2008;14:561-71 pubmed 出版商
  222. Rigau V, Morin M, Rousset M, de Bock F, Lebrun A, Coubes P, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain. 2007;130:1942-56 pubmed